Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity

NCT00608465 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Lack of enrollment

Conditions

Metabolic Syndrome X

Interventions

DRUG: Eplerenone
DRUG: Ramipril

Sponsor

Vanderbilt University